Correlation Between OBI Pharma and SynCore Biotechnology
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and SynCore Biotechnology Co, you can compare the effects of market volatilities on OBI Pharma and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and SynCore Biotechnology.
Diversification Opportunities for OBI Pharma and SynCore Biotechnology
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between OBI and SynCore is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of OBI Pharma i.e., OBI Pharma and SynCore Biotechnology go up and down completely randomly.
Pair Corralation between OBI Pharma and SynCore Biotechnology
Assuming the 90 days trading horizon OBI Pharma is expected to under-perform the SynCore Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, OBI Pharma is 1.26 times less risky than SynCore Biotechnology. The stock trades about -0.13 of its potential returns per unit of risk. The SynCore Biotechnology Co is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 3,685 in SynCore Biotechnology Co on August 29, 2024 and sell it today you would lose (50.00) from holding SynCore Biotechnology Co or give up 1.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
OBI Pharma vs. SynCore Biotechnology Co
Performance |
| Timeline |
| OBI Pharma |
| SynCore Biotechnology |
OBI Pharma and SynCore Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OBI Pharma and SynCore Biotechnology
The main advantage of trading using opposite OBI Pharma and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.| OBI Pharma vs. TaiMed Biologics | OBI Pharma vs. PharmaEngine | OBI Pharma vs. Medigen Biotechnology | OBI Pharma vs. TTY Biopharm Co |
| SynCore Biotechnology vs. Shan Loong Transportation Co | SynCore Biotechnology vs. STL Technology Co | SynCore Biotechnology vs. Chung Hwa Food | SynCore Biotechnology vs. United Radiant Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |